Shanghai Minimally Invasive Surgery Center
29
7
8
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.9%
2 terminated/withdrawn out of 29 trials
71.4%
-15.1% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
Role: lead
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC
Role: lead
Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers
Role: collaborator
A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer
Role: lead
Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer
Role: lead
A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer
Role: lead
Resection Margin of Transverse Colon Cancer With Extracorporeal Versus Intracorporeal Anastomosis
Role: lead
the Value of Transanal Endoscopic ISR
Role: lead
Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy
Role: lead
Exploratory Single-arm, Single-center Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer With Combination of Palizumab and SOX Regimen
Role: lead
Transvaginal NOSES Versus Conventional Laparoscopic Surgery for Right Hemicolectomy
Role: lead
Medial Border of Laparoscopic D3 Lymphadenectomy for Right Colon Cancer
Role: lead
Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
Role: lead
Multiple Firings in Double-stapled Colorectal Anastomosis
Role: lead
The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Gastric Cancer
Role: lead
The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer
Role: lead
Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical Institution
Role: lead
Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China
Role: lead
Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Role: lead
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
Role: lead